Brief: Boston Therapeutics and advance pharmaceutical expand agreement to market Sugardown(R) in 12 additional countries in Asia
21/11/2014 12:41
Nov 21 (Reuters) - Boston Therapeutics Inc BTHE.OB : * Boston Therapeutics and advance pharmaceutical expand agreement to market Sugardown(R) in 12 additional countries in Asia * Source text for Eikon ID:nMKWVcst3a * Further company coverage BTHE.OB ((Bangalore Newsroom; +1 646 223 8780))
Recent news on Nanomix
See all newsBrief: Nanomix Partners With Mobility Health
Brief: Nanomix Corp Enters Into Distribution Agreement With Bioasia Pte Ltd
Brief: Nanomix announces ISO 134852016 certification for its new facility in San Leandro, CA
Brief: Nanomix Announces Appoints Life Sciences Executive Thomas Schlumpberger As CEO And Member Of The Board Of Directors
Brief: Nanomix Completes 1-For-173 Reverse Stock Split